3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
4
Recruiting
2
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Myasthenia Gravis
1
Interventions
zilucoplan
1
rozanolixizumab
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Myasthenia Gravis
×
zilucoplan
×
Clear all
NCT06435312
2026-05-08
ziMyG+
UCB Pharma
Phase 3
Enrolling by invitation
8 enrolled